531633 logo

Lincoln Pharmaceuticals Limited Stock Price

BSE:531633 Community·₹11.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

531633 Share Price Performance

₹585.80
34.25 (6.21%)
₹585.80
34.25 (6.21%)
Price ₹585.80

531633 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

0 Risks
1 Reward

Lincoln Pharmaceuticals Limited Key Details

₹6.5b

Revenue

₹3.1b

Cost of Revenue

₹3.4b

Gross Profit

₹2.6b

Other Expenses

₹878.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
43.85
52.76%
13.47%
0.009%
View Full Analysis

About 531633

Founded
1979
Employees
1853
CEO
Mahendrabhai Patel
WebsiteView website
www.lincolnpharma.com

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.

Recent 531633 News & Updates

Recent updates

No updates